Cognoptix

Daily

Startup aims to diagnose Alzheimer’s through simple eye test; raises $15M

Confirming an Alzheimer’s diagnosis today takes a multi-pronged approach: Doctors evaluate a patient’s mood and cognition, conduct basic neurological tests and perform brain imaging scans to gauge a patient’s likelihood of having the devastating disease. A Massachusetts startup is circumventing this time-consuming process by developing a quick, in-office eye test for the early diagnosis of Alzheimer’s disease. Cognoptix has […]

By Meghana Keshavan
presented by
Devices & Diagnostics

One to watch: Medical device company says eye test can diagnose Alzheimer’s

Cognoptix, Inc. claims to have created a working, in-office, non-invasive eye-scan that detects Alzheimer’s earlier in patients. The SAPPHIRE II tracks a beta amyloid (“Ab”) signature in the eyes of potential Alzheimer’s patients. In a 10-subject, proof-of-concept clinical trial, the drug-device picked up a 200 percent differentiation factor between five healthy volunteers and five patients […]

By Lindsey Alexander